K-TRACKTM next-generation sequencing assay provides critical insights for a patient's genomic profile, allowing precise identification of treatment eligibility and also provides longitudinal ctDNA monitoring that showed clinical utility in predicting disease-free survival and early relapse detection in cancer patients